Veru Inc (VERU): Veru Inc Initiated with a Buy at Maxim G...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	43
Posts	6861
Boards Moderated	0
Alias Born	01/31/2004

ctb

Re: None

Tuesday, 07/03/2018 9:08:15 AM

Tuesday, July 03, 2018 9:08:15 AM

Veru Inc Initiated with a Buy at Maxim Group
July 3, 2018, 7:28 AM EDT

Veru Inc (NASDAQ: VERU) received a Buy rating and a $10 price target from Maxim Group analyst Jason McCarthy today. The company’s shares closed yesterday at $1.95.

McCarthy wrote:

“We are initiating coverage of Veru Inc. with a $10 price target. Veru is a commercial-stage company (female/male health) with a pipeline of both 505(b)(2) and novel products that address benign prostatic hyperplasia (BPH), overactive bladder (OAB), and prostate cancer (PC).”

According to TipRanks.com, McCarthy is a 4-star analyst with an average return of 9.9% and a 39.3% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as IntelliPharmaCeutics International, SELLAS Life Sciences Group Inc, and ContraVir Pharmaceuticals Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Veru Inc with a $7.50 average price target.

https://www.smarteranalyst.com/brief/veru-inc-initiated-with-a-buy-at-maxim-group/

VERU